A detailed history of Bare Financial Services, Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Bare Financial Services, Inc holds 147 shares of ARWR stock, worth $6,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147
Previous 48 206.25%
Holding current value
$6,065
Previous $758,000 568.87%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$14.71 - $34.49 $1,456 - $3,414
99 Added 206.25%
147 $5.07 Million
Q2 2025

Aug 13, 2025

BUY
$9.99 - $16.97 $479 - $814
48 New
48 $758,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $4.37B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Bare Financial Services, Inc Portfolio

Follow Bare Financial Services, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bare Financial Services, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bare Financial Services, Inc with notifications on news.